Nerandomilast (Jascayd; Boehringer Ingelheim) received a recommendation for marketing authorization from the European ...
Banks can now deploy digital asset payments faster, without risking fragmentation ...
The Oscar-winning actress shares what she learned as a caregiver, and what doctors can do to give patients with IPF more hope ...
Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease in which lung tissue becomes scarred, making it hard to ...
Mixed κ agonism and μ antagonism/partial agonism raises mechanistic and abuse-liability questions, with nausea, vomiting, ...
What is Idiopathic Pulmonary Fibrosis (IPF)? IPF is a chronic, progressive, lung disease characterized by disabling shortness of breath, declining exercise capacity and extensive formation of scar ...
Sex differences in the lung proteome at baseline may contribute to sex-specific susceptibility, disease progression, and clinical outcomes in IPF.
MannKind Corporation (NASDAQ:MNKD) is one of the most promising penny stocks according to Wall Street analysts. On June 3, ...
Pharmaceutical Technology on MSN
Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF
The approval is based on Phase III FIBRONEER-IPF and FIBRONEER-ILD clinical trials conducted in parallel.
What is idiopathic pulmonary fibrosis (IPF)? Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal lung disease that affects approximately 3 million people worldwide. Despite the condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results